Advertisement
NeuroScientistNews
NeuroScientistNews

The Scientist

» fraud and immunology

Most Recent

image: Scientists Review Own Papers

Scientists Review Own Papers

By | October 3, 2012

In the latest effort to boost publication records, researchers are writing positive peer reviews for their work under other scientists’ names.

0 Comments

image: Drug Allergy in the Pocket

Drug Allergy in the Pocket

By | October 1, 2012

An HIV drug can bind to and alter the function of an immune molecule, causing a dangerous reaction in patients with a particular allele.

0 Comments

image: 2012 Labbies Honorable Mentions

2012 Labbies Honorable Mentions

By | October 1, 2012

Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.

0 Comments

image: Solving Irreproducible Science

Solving Irreproducible Science

By | September 26, 2012

Will the recently launched Reproducibility Initiative succeed in cleaning up research and reducing retractions?

12 Comments

image: Opinion: Cell Phone Health Risk?

Opinion: Cell Phone Health Risk?

By | September 25, 2012

Security concerns during the Cold War may have led to the generation of misinformation on the physiological effects of microwave radiation from mobile phones.

12 Comments

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Cancer-Causing Gut Bacteria

Cancer-Causing Gut Bacteria

By | August 17, 2012

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

1 Comment

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies